PDI, Inc.  

(Public, NASDAQ:PDII)   Watch this stock  
Find more results for Nancy G Sullivan´┐Ż
2.04
0.00 (0.00%)
Real-time:   12:36PM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range 1.74 - 2.09
52 week 1.00 - 3.00
Open 2.02
Vol / Avg. 79,470.00/67,726.00
Mkt cap 35.68M
P/E     -
Div/yield     -
EPS -1.04
Shares 16.72M
Beta 0.59
Inst. own 38%
Nov 2, 2015
Q3 2015 PDI Inc Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Aug 13, 2015
Q2 2015 PDI Inc Earnings Call - Webcast
Aug 13, 2015
Q2 2015 PDI Inc Earnings Release
Jun 3, 2015
PDI Inc Annual Shareholders Meeting
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin -18.48% -7.84%
Operating margin -16.34% -11.23%
EBITD margin - -7.50%
Return on average assets -24.46% -10.17%
Return on average equity -200.06% -35.75%
Employees 775 -
CDP Score - -

Address

300 Interpace Pkwy
PARSIPPANY, NJ 07054-1100
United States - Map
+1-862-2077800 (Phone)
+1-302-6745266 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

PDI, Inc. provides outsourced commercial services to established and emerging pharmaceutical, biotechnology and healthcare companies in the United States. The Company is a provider of outsourced sales teams that focus on healthcare providers, offering a range of complementary sales support services designed to achieve its customers' strategic and financial product objectives. In addition to outsourced sales teams, it also provides other promotional services, including clinical educator services, digital communications, tele detailing and with the formation of its new business unit, Interpace BioPharma that provides pharmaceutical, biotechnology, medical device and diagnostics clients with full-service product commercialization solutions. The Company has three segments: Sales Services; Marketing Services and Product Commercialization Services (PC Services).

Officers and directors

Gerald P. Belle Independent Chairman of the Board
Age: 69
Bio & Compensation  - Reuters
Nancy S. Lurker Chief Executive Officer, Director
Age: 58
Bio & Compensation  - Reuters
Graham G. Miao Ph.D. Chief Financial Officer, Executive Vice President, Treasurer
Age: 50
Bio & Compensation  - Reuters
Gerald R. Melillo Jr. President - Sales Services
Age: 54
Bio & Compensation  - Reuters
Heiner Dreismann Ph.D. Director
Age: 61
Bio & Compensation  - Reuters
John C. Federspiel Independent Director
Age: 61
Bio & Compensation  - Reuters
Veronica A. Lubatkin CPA Independent Director
Age: 51
Bio & Compensation  - Reuters
Jack E. Stover Independent Director
Age: 62
Bio & Compensation  - Reuters
Stephen J. Sullivan Independent Director
Age: 68
Bio & Compensation  - Reuters